NO20016242L - Tiofen-A2A-reseptoragonister - Google Patents

Tiofen-A2A-reseptoragonister

Info

Publication number
NO20016242L
NO20016242L NO20016242A NO20016242A NO20016242L NO 20016242 L NO20016242 L NO 20016242L NO 20016242 A NO20016242 A NO 20016242A NO 20016242 A NO20016242 A NO 20016242A NO 20016242 L NO20016242 L NO 20016242L
Authority
NO
Norway
Prior art keywords
thiophene
receptor agonists
disclosed
purposes
alkylthienyl
Prior art date
Application number
NO20016242A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016242D0 (no
Inventor
Jeff A Zablocki
Elfatih O Elzein
Venkata P Palle
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of NO20016242D0 publication Critical patent/NO20016242D0/no
Publication of NO20016242L publication Critical patent/NO20016242L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20016242A 1999-06-22 2001-12-19 Tiofen-A2A-reseptoragonister NO20016242L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14047899P 1999-06-22 1999-06-22
PCT/US2000/016856 WO2000078776A2 (en) 1999-06-22 2000-06-20 Thiophene a2a receptor agonists

Publications (2)

Publication Number Publication Date
NO20016242D0 NO20016242D0 (no) 2001-12-19
NO20016242L true NO20016242L (no) 2002-02-21

Family

ID=22491411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016242A NO20016242L (no) 1999-06-22 2001-12-19 Tiofen-A2A-reseptoragonister

Country Status (19)

Country Link
US (1) US6440948B1 (xx)
EP (1) EP1194441B1 (xx)
JP (1) JP2003502434A (xx)
KR (1) KR100463694B1 (xx)
CN (1) CN1166677C (xx)
AT (1) ATE252595T1 (xx)
AU (1) AU768530B2 (xx)
BR (1) BR0011853A (xx)
CA (1) CA2373410C (xx)
DE (1) DE60006116T2 (xx)
ES (1) ES2206259T3 (xx)
HK (1) HK1048821B (xx)
IL (2) IL147194A0 (xx)
MX (1) MXPA01013323A (xx)
NO (1) NO20016242L (xx)
NZ (1) NZ516336A (xx)
TR (1) TR200200617T2 (xx)
WO (1) WO2000078776A2 (xx)
ZA (1) ZA200200299B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121372B1 (en) * 1998-10-16 2006-06-28 Pfizer Limited Adenine derivatives
KR20040097126A (ko) 2002-02-15 2004-11-17 씨브이 쎄러퓨틱스, 인코포레이티드 의료 장치용 중합체 코팅
TWI346109B (en) * 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
US7423144B2 (en) 2004-05-26 2008-09-09 Inotek Pharmaceuticals Corporation Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof
EP1802316B1 (en) * 2004-09-20 2011-11-02 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
CN102711771B (zh) 2010-01-11 2016-05-18 伊诺泰克制药公司 降低眼压的组合、试剂盒和方法
CN102933593A (zh) 2010-03-26 2013-02-13 伊诺泰克制药公司 使用n6-环戊基腺苷（cpa）、cpa衍生物或其前药降低人眼内压的方法
EA027109B1 (ru) 2012-01-26 2017-06-30 Инотек Фармасьютикалс Корпорейшн Безводные полиморфы [(2r,3s,4r,5r)-5-(6-(циклопентиламино)-9h-пурин-9-ил)-3,4-дигидрокситетрагидрофуран-2-ил]метилнитрата и способы их получения
MX2015013234A (es) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.
CA3049856C (en) 2017-01-13 2021-10-26 Tobishi Pharmaceutical Co., Ltd. Neutrophil activation regulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135130B (da) * 1970-12-28 1977-03-07 Takeda Chemical Industries Ltd Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf.
JPS4911896A (xx) * 1972-05-15 1974-02-01
JPS5518625B2 (xx) * 1973-07-26 1980-05-20
US5070877A (en) 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
PL297372A1 (en) * 1991-04-06 1993-09-06 Fisons Plc Atp analogs

Also Published As

Publication number Publication date
NO20016242D0 (no) 2001-12-19
DE60006116T2 (de) 2004-07-08
MXPA01013323A (es) 2003-10-15
DE60006116D1 (de) 2003-11-27
ZA200200299B (en) 2003-08-27
ES2206259T3 (es) 2004-05-16
NZ516336A (en) 2004-01-30
ATE252595T1 (de) 2003-11-15
WO2000078776A3 (en) 2001-06-28
CA2373410C (en) 2006-08-29
BR0011853A (pt) 2002-04-30
TR200200617T2 (tr) 2002-06-21
KR100463694B1 (ko) 2004-12-29
JP2003502434A (ja) 2003-01-21
KR20020028912A (ko) 2002-04-17
US6440948B1 (en) 2002-08-27
EP1194441B1 (en) 2003-10-22
CN1364170A (zh) 2002-08-14
CN1166677C (zh) 2004-09-15
HK1048821B (zh) 2005-02-25
IL147194A0 (en) 2002-08-14
IL147194A (en) 2007-08-19
WO2000078776A2 (en) 2000-12-28
AU768530B2 (en) 2003-12-18
EP1194441A2 (en) 2002-04-10
HK1048821A1 (en) 2003-04-17
CA2373410A1 (en) 2000-12-28
AU5625100A (en) 2001-01-09

Similar Documents

Publication Publication Date Title
BRPI0011856B8 (pt) agonistas de receptor a2a de n-pirazol
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
NZ522326A (en) Adenosine A2A receptor antagonists
ATE252595T1 (de) A2a rezeptor agonisten
MA26699A1 (fr) Derives d'adenine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MY148937A (en) Medicaments with hm74a receptor activity
TR200201001T2 (tr) Pürin türevleri
UA66945C2 (uk) ПОХІДНІ ПУРИНУ З ВЛАСТИВОСТЯМИ АГОНІСТА ЛЮДСЬКОГО А2<sub>А</sub> РЕЦЕПТОРА, СПОСІБ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
DK0975595T3 (da) Kokainanaloger
JP2013502424A5 (xx)
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
NO20021448L (no) Nye tiazolo-(4,5-D)pyrimidinforbindelser
BR0011850A (pt) Agonistas de receptor a2a de propargil fenil éter
FI884375A (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
TR200103680T2 (tr) IL-8 reseptör antagonistleri.
EA200200562A1 (ru) Антагонисты аденозиновых рецепторов и способы их получения и использования
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
MXPA05012369A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.
CN100480255C (zh) A1腺苷受体的部分和完全激动剂
ES2222975T3 (es) Uso de antagonistas de pirimidina endotelina en animales de compañia.
DE60008589D1 (de) Zusammensetzungen von adenosin a1 agonisten mit 5ht1 agonisten
SE9903609D0 (sv) Novel compounds I
SE8504708D0 (sv) Novel nucleoside derivatives having antiherpetic properties, pharmaceutical compositions comprising same and process for the preparation of the active ingredients

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application